Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00684138 · ClinicalTrials.gov registry record · Phase 4
ACRYSOF® ReSTOR® Aspheric +3.0 D Add Power Intraocular Lens (IOL)
A Phase 4 study, sponsored by Alcon Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 300
- Enrollment target
NCT00684138 is a Phase 4 study that has completed, run by Alcon Research. The registered enrollment target is 300 participants.
The verdict
NCT00684138, a Phase 4 study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 300 participants
- Enrollment target
Study Summary
Randomized, parallel group, subject masked, multi-center six (6) month follow-up study comparing ACRYSOF® ReSTOR® Aspheric +3.0 D Add Power IOL Model SN6AD1 implanted in both eyes to ACRYSOF® ReSTOR® Aspheric +4.0 D Add Power IOL Model SN6AD3 implanted in both eyes.
Interventions
- DEVICE ACRYSOF® ReSTOR® Aspheric +4.0 D Add Power Intraocular Lens
- DEVICE ACRYSOF® ReSTOR® Aspheric +3.0 D Add Power Intraocular Lens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2007-06 |
| Est. Completion | 2008-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00684138
The ClinicalTrials.gov registry entry for NCT00684138 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ACRYSOF® ReSTOR® Aspheric +4.0 D Add Power Intraocular Lens is the first listed.
NCT00684138 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00684138 about?
NCT00684138 is a clinical study titled "ACRYSOF® ReSTOR® Aspheric +3.0 D Add Power Intraocular Lens (IOL)". Randomized, parallel group, subject masked, multi-center six (6) month follow-up study comparing ACRYSOF® ReSTOR® Aspheric +3.0 D Add Power IOL Model SN6AD1 implanted in both eyes to ACRYSOF® ReSTOR® Aspheric +4.0 D Add Power IOL Model SN6AD3 implanted in both eyes.
What is the current status of trial NCT00684138?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 300 participants. The study started on 2007-06. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00684138?
The interventions under investigation include: ACRYSOF® ReSTOR® Aspheric +4.0 D Add Power Intraocular Lens (DEVICE), ACRYSOF® ReSTOR® Aspheric +3.0 D Add Power Intraocular Lens (DEVICE).
Who is sponsoring clinical trial NCT00684138?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.